#Placebo

A. Febrina Sugianto

febrinasugianto

Hai! Aku mau bahas vaksin SINOVAC ya jadi, BPOM sudah mengumumkan hasil sementara uji klinis fase 3 vaksin Sinovac di Indonesia memiliki efikasi 65.3%. Efikasi 65.3% itu artinya dari 100

Hilda Bastian, PhD

hildabast

The FDA will start releasing phase 3 trial data on Covid vaccine any moment now & a media deluge will start! Tips on what to watch out for | My

Catherine Smith, MD

SmithLabSF

Ok, one last thread with #FinalFLT3 thoughts on today’s #AML talks. #ASH20 #ASHFromHome #ASHtogether #leusm 1) First, Dr. Andrew Wei with an excellent presentation on AML M16 (sor vs placebo

Caroline Seydel

CarolineSeydel

“Why would anyone take a vaccine that’s 94% effective for a disease with a 99% survival rate?”The problem with this logic is that the 99% and 94% don’t mean the

Coronavirus update

Bita33088889

#Covid19SA A thread I hear some people are very upset that rokeout of AZ is postponed until enough data is available!Decisions made by of our scientist is correct& responsible.Welcome to

Isabel Goldman

isabelgoldm

1/5: Researchers assessed the quality of RCTs looking at HRT in #trans women. Not surprisingly, they identified only 1 trial.#TransJournalWatch @CochraneLibrary https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013138.pub2/full 2/

انوری بیگم

AnwariBeghum

Interesting fact that we learned today is that the old treatment of a Ganglion (which is basically a cystic degeneration of tissues) was to hit it with the family Bible

Anupam Singh

anupampom

DGCI clears Biocon's anti-CD-6 inhibitor for Moderate to Severe COVID Patients for Restricted Emergency Use.https://www.news18.com/news/india/dcgi-approves-psoriasis-injection-itolizumab-for-restricted-emergency-use-to-treat-covid-19-pa

Jim McManus OCDS

jimmcmanusph

There have been news reports that a recent study found the Oxford/AstraZeneca #Covid19 #vaccine is “less effective” against the South African Variant of the virus. This does NOT mean that

Heather 🇺🇸🏴‍☠️

featherty

My covid vaccine story:In July, I read that Dr. Fauci was concerned we might not have enough volunteers for coronavirus vaccine trials. So I went to the NIH website and

Louis-Alexandre Alciator

AlciatorLA

Première étude disponible sur le vaccin Pfizer.https://www.nejm.org/action/doSecureKeyLogin?uri=https%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2034577%3Fquery%3DRP&uuid=11698682&dateTime=202012200000&key=BXcfdgqC5jT

Andy Slavitt @ 🏡🇺🇸

ASlavitt

More news on Vaccine trial pause after I get off the air with CNBC Asia. Follow if interested. Important background below.https://twitter.com/aslavitt/status/1303706627611258880 The CEO of @AstraZeneca held a PRIVATE conference call

Ph.Gabriel Steg

gabrielsteg

Clinical Trial Challenges in the COVID-19 era. A Thread Logistical challenges: enrolment window is short- need to fast track all procedures (writing, IRB, regulatory approval, funding application)- drug needs to

Samuel Brown

DrSamuelBrown

I'm thinking more about the Pfizer vaccine (and grateful for those who have clarified some key points). First, I agree that early efficacy (right after the second injection) prevents infection

Dr Bryan McElroy

BryanMcElroy8

More an more patients are being treated for mild/ moderate depression with #antidepressants in general practice, despite there being very poor evidence for efficacy. In my experience, some people experience

Theo Sanderson

theosanderson

1/ Had another look at the new Maccabi data. (tl;dr: things look good, but nothing beats a randomised trial) https://theo.io/post/2021-01-31-maccabi-2/ 2/ I extracted the data from the "MHS" Kaplan-Meier plot

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.